{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-tmf-filing-during-the-trial-quality-checks-timeliness”
},
“headline”: “SOP for TMF Filing During the Trial (Quality Checks, Timeliness)”,
“description”: “This SOP defines the step-by-step procedures for filing documents into the Trial Master File (TMF) during an ongoing trial, ensuring contemporaneous updates, quality checks, version control, and inspection readiness in compliance with FDA, EMA, CDSCO, WHO, and ICH GCP requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for TMF Filing During the Trial (Quality Checks, Timeliness)

Purpose

The purpose of this SOP is to establish a standardized process for contemporaneous filing of essential documents into the Trial Master File (TMF) during the conduct of a clinical trial. This ensures that all trial-related records are accurate, complete, current, and readily available for inspection by regulatory authorities.

Scope

This SOP applies to sponsor staff, CROs, monitors (CRAs), TMF administrators, and QA officers responsible for filing, maintaining, and reviewing trial-related essential documents in TMF/eTMF during the trial. It includes timelines, quality control, reconciliation, versioning, and compliance monitoring for global clinical studies.

Responsibilities

• Sponsor: Ensures TMF/eTMF is accurate, contemporaneous, and inspection-ready.
• CRO: May manage TMF on behalf of sponsor, but oversight remains with sponsor.
• Clinical Operations: Ensures timely submission of documents for filing.
• CRA: Collects and submits site-level documents for TMF filing.
• TMF Administrator: Files documents, manages placeholders, performs QC checks.
• QA: Audits TMF periodically for compliance and inspection readiness.

Accountability

The Head of Clinical Operations is accountable for overall TMF completeness. TMF administrators are accountable for timeliness and accuracy of filing, while QA is accountable for verifying quality standards.

Procedure

1. Document Collection and Submission
1.1 CRAs and study staff must submit finalized essential documents (e.g., approvals, consents, monitoring reports) within 5 working days of finalization.
1.2 Documents should be submitted in controlled formats (signed originals, certified copies, or validated e-documents).
1.3 TMF placeholders must be updated until documents are available.

2. Filing into TMF/eTMF
2.1 TMF administrators classify and index documents as per TMF structure and DIA Reference Model.
2.2 File documents under “During the Trial” section in TMF index.
2.3 Ensure documents are filed only once and in correct section; duplicates must be avoided.
2.4 Apply audit trails (electronic) or date/initial stamps (paper).

3. Timeliness Requirements
3.1 All essential documents must be filed within 5 working days of receipt/finalization.
3.2 Exceptions must be justified in TMF Filing Deviation Log (Annexure-1).
3.3 Monthly metrics for timeliness (% filed on time) must be tracked.

4. Quality Control Checks
4.1 Perform QC on 10% of documents filed weekly.
4.2 QC includes verifying signatures, dates, version control, completeness, and accuracy.
4.3 Record QC results in TMF QC Log (Annexure-2).
4.4 Discrepancies must be corrected within 10 working days.

5. Reconciliation and Tracking
5.1 Monthly reconciliation must be conducted between TMF, ISF, and monitoring reports.
5.2 Track missing documents in TMF Reconciliation Log (Annexure-3).
5.3 Notify responsible function (site/CRO/sponsor) for overdue documents.

6. Version Management
6.1 Superseded versions must be archived and controlled.
6.2 For eTMF, audit trails must capture changes; for paper TMF, stamp “Superseded.”
6.3 Document corrections must follow SOP for Document Corrections.

7. Ongoing Compliance and Inspection Readiness
7.1 TMF must be inspection-ready at all times.
7.2 Monthly TMF completeness and timeliness reports must be generated.
7.3 QA audits TMF quarterly and documents findings in QA Audit Log.

Abbreviations

• SOP: Standard Operating Procedure
• TMF/eTMF: Trial Master File / electronic Trial Master File
• CRA: Clinical Research Associate
• QC: Quality Control
• QA: Quality Assurance
• DIA: Drug Information Association
• ISF: Investigator Site File

Documents

1. TMF Filing Deviation Log (Annexure-1)
2. TMF QC Log (Annexure-2)
3. TMF Reconciliation Log (Annexure-3)

References

• ICH E6(R2/R3) – Essential Documents During Trial
• FDA – TMF Filing Guidance
• EMA – TMF Filing and Maintenance
• CDSCO – Essential Documents Filing
• WHO – TMF Quality and Timeliness

Version: 1.0

Approval Section

Annexures

Annexure-1: TMF Filing Deviation Log

Annexure-2: TMF QC Log

Annexure-3: TMF Reconciliation Log

Revision History

For more SOPs visit: Pharma SOP